Kristian Bjøro

• Dalgard, Olav; Martinot-Peignoux, Michelle; Verbaan, Hans; Bjøro, Kristian; Ring-Larsen, Helmer & Marcellin, Patrick (2015). The usefulness of defining rapid virological response by a very sensitive assay (TMA) during treatment of HCV genotype 2/3 infection. PLOS ONE. ISSN 1932-6203. 10(8). doi: 10.1371/journal.pone.0120866.
• Fosby, Bjarte; Melum, Espen; Bjøro, Kristian; Bennet, William; Rasmussen, Allan & Andersen, Ina Riise [Vis alle 30 forfattere av denne artikkelen] (2015). Liver transplantation in the Nordic countries-An intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 50(6), s. 797–808. doi: 10.3109/00365521.2015.1036359.
• Eskesen, Arne N; Bjøro, Kristian; Aandahl, Einar Martin; Line, Pål Dag & Melum, Espen (2014). Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway-A population-based cohort study. Cancer Epidemiology. ISSN 1877-7821. 38(6), s. 741–747. doi: 10.1016/j.canep.2014.10.005.
• Eskesen, Arne N; Melum, Espen; Moghaddam, Amir; Bjøro, Kristian; Verbaan, Hans & Ring-Larsen, Helmer [Vis alle 7 forfattere av denne artikkelen] (2012). Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort. European Journal of Gastroenterology and Hepathology. ISSN 0954-691X. 24(8), s. 890–896. doi: 10.1097/MEG.0b013e3283546efd.
• Moghaddam, Amir; Melum, Espen; Reinton, Nils; Ring-Larsen, Helmer; Verbaan, Hans & Bjøro, Kristian [Vis alle 7 forfattere av denne artikkelen] (2011). IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection. Hepatology. ISSN 0270-9139. 53(3), s. 746–754. doi: 10.1002/hep.24154.
• Dahl, Tuva Børresdatter; Haukeland, John Willy; Yndestad, Arne; Ranheim, Trine; Gladhaug, Ivar Prydz & Damås, Jan Kristian [Vis alle 16 forfattere av denne artikkelen] (2010). Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease. Journal of Clinical Endocrinology and Metabolism (JCEM). ISSN 0021-972X. 95(6), s. 3039–3047. doi: 10.1210/jc.2009-2148.
• Dalgard, Olav; Bjøro, Kristian; Ring-Larsen, H. & Verbaan, H (2010). In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials. European Journal of Gastroenterology and Hepathology. ISSN 0954-691X. 22(5), s. 552–556. doi: 10.1097/MEG.0b013e328335b29e.
• Haukeland, John Willy; Zbigniew, Konopski; Eggesbø, Heidi Beate; von Volkmann, HL; Raschpichler, G & Bjøro, Kristian [Vis alle 9 forfattere av denne artikkelen] (2009). Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 44(7), s. 853–860. doi: 10.1080/00365520902845268.
• Haukeland, John Willy; Damås, Jan Kristian; Konopski, Zbigniew; Loberg, EM; Haaland, T & Goverud, I [Vis alle 10 forfattere av denne artikkelen] (2006). Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. Journal of Hepatology. ISSN 0168-8278. 44(6), s. 1167–1174.
• Brandsæter, Bjørn Jardar; Schrumpf, Erik; Bentdal, Øystein H.; Braband, Knut; Smith, Hans-Jørgen & Abildgaard, Andreas [Vis alle 8 forfattere av denne artikkelen] (2005). Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver transplantation. ISSN 1527-6465. 11(11), s. 1361–1369.
• Haukeland, John Willy; Zbigniew, Konopski; Linnestad, P.; Azimy, S.; Løberg, Else Marit & Haaland, T. [Vis alle 8 forfattere av denne artikkelen] (2005). Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 40(12), s. 1469–77.
• Bjøro, Kristian; Schou, IH; Smeby, Nina Aarhus & Hamilton, G (2004). A strategy for establishing hospital based Nursing Research in Norway. Vård i Norden. ISSN 0107-4083. 24(1), s. 42–44.
• Dalgaard, O; Bjøro, Kristian; Block Hellum, K; Myrvang, B; Ritland, S & Skaug, K [Vis alle 8 forfattere av denne artikkelen] (2004). Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 og 3 for 14 weeks: a pilot study. Hepatology. ISSN 0270-9139. 40, s. 1260–1265.
• Brandsæter, Bjørn Jardar; Schrumpf, Erik; Clausen, Ole Petter Fraas; Abildgaard, Andreas; Hafsahl, Geir & Bjøro, Kristian (2004). Recurrent sclerosing cholangitis or ischemic bile duct lesions - a diagnostic challenge? Liver transplantation. ISSN 1527-6465. 10(8), s. 1073–1074.
• Brandsæter, Bjørn Jardar; Isoniemi, H; Broome, U; Olausson, M; Backman, L & Hansen, B [Vis alle 14 forfattere av denne artikkelen] (2004). "Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy". Journal of Hepatology. ISSN 0168-8278. 40, s. 815–822.
• Rokkones, Erik; Fromm, Sigurd H.; Kareem, Najma B.; Klungland, Helge; Olstad, Ole K. & Høgset, Anders [Vis alle 9 forfattere av denne artikkelen] (1995). Human Parathyroid Hormone as a Secretory Peptide in Milk of Transgenic Mice. Journal of Cellular Biochemistry. ISSN 0730-2312. 59, s. 168–176.

Se alle arbeider i Cristin

• Jørgensen, Silje Fjellgård; Macpherson, Magnhild E; Bjøro, Kristian; Karlsen, Tom Hemming; Reims, Henrik Mikael & Grzyb, Krzysztof [Vis alle 10 forfattere av denne artikkelen] (2016). Liver transplantation in patients with primary antibody deficiency. Journal of Allergy and Clinical Immunology. ISSN 0091-6749. doi: 10.1016/j.jaci.2016.10.025.
• Dalgard, Olav; Moghaddam, Amir; Verbaan, Hans; Ring-Larsen, Helmer; Bjøro, Kristian & Melum, Espen (2010). IL28B GENETIC VARIATION AND TREATMENT RESPONSE IN PATIENTS WITH HCV GENOTYPE 3 INFECTION. Hepatology. ISSN 0270-9139. 52(4), s. 751A–751A.
• Bjøro, Kristian (2010). This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 45(6), s. 643–644. doi: 10.3109/00365521.2010.488881.
• Carvalho, RJ; Verbaan, H; Bjøro, Kristian; Ring-Larsen, H & Dalgard, O (2009). LOW-TO-MODERATE ALCOHOL CONSUMPTION HAS NO IMPACT ON ANTIVIRAL RESPONSE TO COMBINATION THERAPY IN HCV PATIENTS WITH GENOTYPE 2 OR 3. Hepatology. ISSN 0270-9139. 50(4), s. 687A–688A.
• Schrumpf, Erik & Bjøro, Kristian (2008). Timing of liver transplantation in PSC. Scandinavian Journal of Gastroenterology. ISSN 0036-5521. 43, s. 31–31.
• Dalgard, Odd Steffen; Bjøro, Kristian; Ring-Larsen, H & Verbaan, H (2008). Is sustained virological response to HCV treatment associated with a clinical important improvement in vitality? Journal of Hepatology. ISSN 0168-8278. 48, s. S272–S272.
• Haukeland, John Willy; Zbigniew, Konopski; Loberg, EM; Haaland, Therese Kristina; von Volkmann, HL & Raschpichler, G [Vis alle 9 forfattere av denne artikkelen] (2008). A RANDOMIZED, PLACEBO CONTROLLED TRIAL WITH METFORMIN IN PATIENTS WITH NAFLD. Hepatology. ISSN 0270-9139. 48(4), s. 334A–334A.
• Dalgard, Olav; Verbaan, H; Ring-Larsen, H & Bjøro, Kristian (2008). IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS. Hepatology. ISSN 0270-9139. 48(4), s. 1148A–1148A.
• Dalgard, O; Bjøro, Kristian; Hellum, K; Myrvang, B; Ritland, S & Skaug, K [Vis alle 8 forfattere av denne artikkelen] (2004). Short (14 weeks) treatment with pegylated interferon alpha-2B and ribavirin in patients with hepatitis C genotype 2/3 virus infection and early virological response. Hepatology. ISSN 0270-9139. 40, s. 252A–252A.

Se alle arbeider i Cristin